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ABSTRACT
The FemXWv aminoacyl transferase of Weissella
viridescens initiates the synthesis of the side chain
of peptidoglycan precursors by transferring L-Ala
from Ala-tRNAAla to UDP-MurNAc-pentadepsipep-
tide. FemXWv is an attractive target for the develop-
ment of novel antibiotics, since the side chain is
essential for the last cross-linking step of peptido-
glycan synthesis. Here, we show that FemXWv is
highly specific for incorporation of L-Ala in vivo
based on extensive analysis of the structure of
peptidoglycan. Comparison of various natural and
in vitro-transcribed tRNAs indicated that the speci-
ficity of FemXWv depends mainly upon the sequence
of the tRNA although additional specificity determi-
nants may include post-transcriptional modifica-
tions and recognition of the esterified amino acid.
Site-directed mutagenesis identified cytosines in
the G1–C72 and G2–C71 base pairs of the acceptor
stem as critical for FemXWv activity in agreement
with modeling of tRNAAla in the catalytic cavity
of the enzyme. In contrast, semi-synthesis of
Ala-tRNAAla harboring nucleotide substitutions in
the G3–U70 wobble base pair showed that this main
identity determinant of alanyl-tRNA synthetase is
non-essential for FemXWv. The different modes of
recognition of the acceptor stem indicate that
specific inhibition of FemXWv could be achieved by
targeting the distal portion of tRNAAla for the design
of substrate analogues.
INTRODUCTION
Bacterial resistance to antibiotics will lead to therapeutic
deadlocks unless new drugs are discovered. Only two
families of antibiotics act on peptidoglycan polymeriza-
tion, the b-lactams and the glycopeptides. Development of
new generations of molecules derived from these anti-
biotics is not suﬃcient to defeat the sophisticated
resistance mechanisms responsible for the gradual loss of
activity against main human pathogens, such as the
pneumococci and the staphylococci, responsible for life-
threatening pneumonia, meningitis and sepsis. Blocking
synthesis of the substrate of peptidoglycan polymerases is
an attractive strategy to develop new antibiotics but this
approach requires a better understanding of the substrate
speciﬁcity and catalytic mechanism of the essential
enzymes since screening of natural substances has led to
very limited success in the discovery of novel molecules.
Here, we report characterization of FemXWv, the model
enzyme of a unique family of tRNA-dependent aminoacyl
transferases that have not been previously explored as
drug targets because of the complexity of their nucleotide
substrate. Key features in the recognition of Ala-tRNAAla
by FemXWv validate these enzymes as potential drug
targets.
The peptidoglycan is an essential component of the
bacterial cell envelope, since it provides a mechanical
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barrier to the internal osmotic pressure of the cytoplasm
(1). The peptidoglycan subunit is assembled by a series of
cytoplasmic and membrane steps (Figure 1) that lead to
formation of nucleotide (UDP-linked) and lipid inter-
mediates. The complete subunit is translocated to the cell
surface by an unknown mechanism and polymerized by
the glycosyltransferases, that form the b-1-4 bonds linking
the repeating GlcNAc–MurNAc units (2), and by the
D,D-transpeptidases, that form peptide bonds between
stem peptides in order to cross-link adjacent glycan
strands (3). The latter activity is the target of b-lactam
antibiotics that mimic the D-Ala4-D-Ala5 extremity of
peptidoglycan precursors (4) and act as ‘suicide’ substrates
in an essentially irreversible acylation reaction (5). In
Gram-positive bacteria, b-lactam resistance is often due to
so-called low-aﬃnity penicillin-binding proteins (PBPs)
that interact poorly with b-lactams and catalyze peptido-
glycan cross-linking in the presence of the drug (3).
A wide variety of modiﬁcations of the disaccharide-
peptide subunit has been detected in mature peptidoglycan
from Gram-positive bacteria, including the addition of
a side chain comprising one to seven amino acids to the
e amino group of L-Lys3 (6). These modiﬁcations are
introduced in the subunit at diﬀerent steps of peptidogly-
can synthesis and can therefore involve the nucleotide
precursor as well as both lipid intermediates (7). The
dicarboxylic amino acid D-Asp is incorporated into
the side chain by aspartate ligases that belong to the
ATPGrasp superfamily and activate their substrate by
ATP-dependent formation of a b-aspartyl-phosphate
intermediary (8). In contrast, L-amino acids and glycine
are activated as aminoacyl-tRNAs (9) and incorporated
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Figure 1. Main steps of peptidoglycan synthesis in W. viridescens. The subunit consists of b-1-4-linked N-acetyl glucosamine (GlcNAc) and N-acetyl
muramic acid (MurNAc) substituted by a depsipeptide which is linked to the D-lactoyl group of MurNAc by an amide bond. The assembly of the
subunit starts in the cytoplasm by the synthesis of UDP-MurNAc, the ﬁrst precursor dedicated to peptidoglycan synthesis (37). In the following
steps, the Mur ligases sequentially add L-Ala, D-Glu, L-Lys, attached to the g carboxyl of D-Glu (D-iGlu) and the depsipeptide D-Ala-D-Lac to form
the stem pentadepsipeptide L-Ala1-D-iGlu2-L-Lys3-D-Ala4-D-Lac5. The FemXWv aminoacyl transferase adds the ﬁrst residue of the side chain onto this
nucleotide precursor. Synthesis of the subunit proceeds by the transfer of the phospho-MurNAc-pentadepsipeptide moiety of UDP-MurNAc-
pentadepsipeptide to the C55 lipid carrier undecaprenyl phosphate to form lipid intermediate I (undecaprenyl-PP-MurNAc-pentadepsipeptide or
lipid I). The addition of GlcNAc to lipid I leads to lipid intermediate II [undecaprenyl-PP-MurNAc-(pentadepsipeptide)GlcNAc] or lipid II. The
second and third residues of the L-Ala-L-Ser and L-Ala-L-Ser-L-Ala side chains are added to the lipid intermediates by unknown Fem transferases.
The a carboxyl of D-iGlu2 is amidated in mature peptidoglycan (D-iGln2). The insets indicate the relative abundance of precursors and muropeptides,
which was determined by the absorbance at 260 and 195 nm, respectively.
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into the side chain by Fem transferases (10) that belong
to the GCN5-related N-acetyltransferase (GNAT) pro-
tein superfamily (11,12). Characterized members of this
family include FemXWv from Weissella viridescens that
transfers L-Ala from L-Ala-tRNAAla to UDP-MurNAc-
pentapeptide (13,14) (Figure 1) and FemABX from
Staphylococcus aureus that sequentially add one (FemX)
or two (FemA and FemB) glycines to lipid II (15).
FemXWv catalysis proceeds by an ordered bi–bi mecha-
nism with sequential ﬁxation of the UDP-MurNAc-
pentapeptide and Ala-tRNAAla substrates and sequential
release of the tRNAAla and UDP-MurNAc-hexapeptide
products (14). Binding of the ﬁrst substrate to FemXWv
involves a complex network of hydrogen bonds and
stacking interactions that constraint UDP-MurNAc-
pentapeptide in a bent conformation essential for transfer-
ase activity (13). The mode of interaction of FemXWv with
the second substrate, Ala-tRNAAla, as well as the catalytic
mechanism of the enzyme remains speculative (14).
The side chain of peptidoglycan precursors assembled
by Fem transferases carries the amine used for peptide
bond formation by the transpeptidases in the last cross-
linking step of peptidoglycan polymerization (Figure 1)
(13,16). The speciﬁcity of Fem transferases is essential for
the bacterium since incorporation of erroneous amino
acids would produce precursors acting as chain termina-
tors, thereby preventing formation of the stress-bearing
peptidoglycan network. In spite of its critical role for the
integrity of peptidoglycan, little is known about the amino
acid speciﬁcity of Fem transferases. Surprisingly, FemXWv
was reported to poorly discriminate between Ala-tRNAAla
and Ser-tRNASer in vitro (14). The speciﬁcity constant
kcat/Km for the two aminoacyl-tRNAs diﬀered only
11-fold implying a likely incorporation of both amino
acids into the peptidoglycan precursors (14). In this
report, we have evaluated the in vivo speciﬁcity of
FemXWv by mass spectrometry analyses of peptidoglycan
and its precursors. The in vitro speciﬁcity of the enzyme
was also evaluated by comparing the catalytic eﬃciency of
the enzyme with natural tRNAs extracted from diﬀerent
bacterial species or obtained by in vitro transcription. The
modes of recognition of the acceptor stem of the tRNA by
FemXWv and alanyl-tRNA synthetase were compared
based on saturation mutagenesis and semi-synthesis of
Ala-tRNAAla analogues.
MATERIALS AND METHODS
Preparation and analysis of cytoplasmic peptidoglycan
precursors
Bacteria were grown at 308C to an optical density at
650 nm of 0.75 in Man, Rogosa and Sharpe (MRS) broth
(Biorad). Bacitracin (250 mg/ml) was added to inhibit
dephosphorylation of undecaprenyl diphosphate and
incubation was continued for 30min to accumulate
cytoplasmic peptidoglycan precursors. Extraction of the
precursors with formic acid and separation by rp-HPLC in
a C18 column with a methanol gradient (0–20%) in
50mM ammonium formiate (pH 4.0) was performed as
previously described (17). The precursors were analyzed
by mass spectrometry using an electrospray time-of-ﬂight
mass spectrometer operating in positive mode (Qstar
Pulsar I, Applied Biosystem, Courtaboeuf, France) (18).
The sequence of the precursors was determined by tandem
mass spectrometry with nitrogen as the collision gas (18).
Peptidoglycan structure analysis
Bacteria were grown at 308C to an optical density of
0.75 at 650 nm in MRS broth. Peptidoglycan was extrac-
ted with boiling SDS, treated with proteases and digested
with mutanolysin and lysozyme, as previously described
(16). The resulting muropeptides were treated with ammo-
nium hydroxide to cleave the ether link in MurNAc,
separated by rp-HPLC and analyzed by mass spectrom-
etry and tandem mass spectrometry (16).
Enzyme production and purification
The same procedures were used for production and
puriﬁcation of the proteins unless speciﬁed otherwise.
Genes were ampliﬁed by PCR and cloned into the vector
pTrc-His60 (19) in order to introduce a C-terminal 6XHis
tag in the recombinant proteins. Derivatives of Escherichia
coli TOP10 harboring recombinant plasmids were grown
to an optical density at 600 nm of 0.7 in brain heart
infusion broth (Difco) containing 100mgml1 of ampicil-
lin, isopropyl-b-D-thiogalactopyranoside was added to a
ﬁnal concentration of 0.5mM, and incubation was
continued overnight at 168C. Bacteria were harvested by
centrifugation (4200g for 30min at 48C), resuspended in
50mM Tris–HCl (pH 7.5) containing 300mM NaCl
(buﬀer A), and disrupted by sonication with a Branson
Soniﬁer 450 for 2min with cooling. The extract was
centrifuged at 13 800 g for 30min at 48C and the
supernatant was mixed with a HIS-SelectTM nickel aﬃnity
gel (SIGMA, Saint Louis, Missouri, USA) for aﬃnity
puriﬁcation. Proteins eluted with imidazole were dialyzed
against buﬀer A containing 100 instead of 300mM NaCl
prior to anion exchange chromatography on a Mono Q
5/50 GL column (Amersham Biosciences, Piscataway,
USA) with an NaCl gradient in Tris–HCl (pH 7.5). Size
exclusion chromatography was performed on a Superdex
75 HR 10/30 column (Amersham Biosciences) equilib-
rated in buﬀer A. Protein concentration was determined
by using the Bradford reagent (Bio-Rad, Munich,
Germany) with bovine serum albumin as a standard.
Proteins were stored at 208C in buﬀer A supplemented
with 50% glycerol.
The recombinant plasmid encoding the FemXWv
transferase ofW. viridescens has been previously described
(13). The protein was puriﬁed by aﬃnity, anion exchange
and size exclusion chromatographies.
The aminoacyl-tRNA synthetases were puriﬁed in two
steps by aﬃnity and anion-exchange chromatographies.
Construction of the recombinant plasmid encoding the
alanyl–tRNA synthetase of Enterococcus faecalis JH2-2
(AlaRS) has been previously described (20). The same
cloning approach was used to construct recombinant
plasmids encoding the glycyl-tRNA synthetase of
S. aureus Mu50 (GlyRS) and one (EF3292) of the two
seryl–tRNA synthetases of E. faecalis JH2-2 (SerRS).
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The gene encoding the T4 RNA ligase was cloned into
pTrc-His60 and the enzyme was puriﬁed by aﬃnity, anion
exchange and size exclusion chromatographies. For
production of the T7 RNA polymerase, we used
a pQE30 derivative in E. coli M15 (a kind gift of
K. Tomita). The protein was puriﬁed in a single step by
nickel aﬃnity chromatography followed by dialysis
against Tris–HCl 50mM (pH 7.5), MgCl2 10mM, KCl
200mM and dithiothreitol 2mM. The protein was stored
in the same buﬀer supplemented with 50% glycerol.
DNA templates for preparation of tRNAs by in vitro
transcription
The sequence of the tRNAAla used in this study
(50-GGGGCCUUAGCUCAGCUGGGAGAGCGCCU
GCUUUGCACGCAGGAGGUCAGCGGUUCGAUC
CCGCUAGGCUCCACCA-30) corresponds to the three
identical sequences annotated as tRNAAla in the genome
sequence of E. faecalis strain V583 (http://www.tigr.org/)
(13). The sequence of the tRNASer (50- GGAGAGUU
GUCCGAGAGGCCGAAGGAGCAUGAUUGGAAA
UCAUGUAGGCGGUAAACACUGUCUCAAGGGU
UCGAAUCCCUUACUCUCCGCCA-30) corresponds to
one of the ﬁve sequences annotated as tRNASer in the
genome of E. faecalis V583. The sequence of the tRNAGly
(50-GCGGGUGUAGUUUAAUGGCAAAACCUCAG
CCUUCCAAGCUGAUGUUGUGGGUUCGAUUCC
CAUCACCCGCUCCA-30) corresponded to two of the
six sequences annotated as tRNAGly in the genome of S.
aureus strain Mu50. The sequence (50-TAATACGAC
TCACTATA-30) (21) containing the T7 promoter was
fused to the DNA templates encoding the tRNAs and
cloned into the vectors pUC18 (tRNAAla and tRNAGly) or
pCRblunt (Invitrogen) (tRNASer). The DNA templates
used for in vitro transcription were obtained by digestion
of these recombinant plasmids with BstNI, as previously
described (21), or alternatively by PCR ampliﬁcation of
a portion of the same recombinant plasmids using primers
50-AGGCTTTACACTTTATGCTTCCGG-30 and 50-TG
GTGGAGCCTAGCGGGAT-30 for tRNAAla, 50-CGA
ATTCGATTTAATACGACTC-30 and 50-TGGCGGAG
AGTAAGGGAT-30 for tRNASer, and 50-GCGGGTGT
AGTTTAATGG-30 and 50-TGGAGCGGGTGATGG
GGA-30 for tRNAGly and DNA fragments used as
templates were puriﬁed by agarose gel electrophoresis.
DNA templates for mutagenesis of tRNAAla
The plasmid templates used to generate the 35- and
36-nucleotide (nt) tRNAAla mini helices were generated by
deleting internal portions of the pUC18 recombinant
plasmid carrying the tRNAAla sequence (above). The
plasmid templates used to generate the 24-nt micro helix
was obtained by hybridizing two oligodeoxyribonucleo-
tides (50-AATTGCTGCAGTAATACGACTCACTATA
GGGGCCTTAGCTCAGGCTCCACCA-30 and 50-TGG
TGGAGCCTGAGCTAAGGCCCCTATAGTGAGTC
GTATTACTGCAGCAATT-30). The same approach
was used generate the two strands of the acceptor stem
(50-CGAATTCGATTTAATACGACTCACTATAGGG
GCCT-30 and 50-AGGCCCCTATAGTGAGTCGTATT
AAATCGAATTCG-30 for the 7-nt transcript; 50-CGAA
TTCGATTTAATACGACTCACTATAAGGCTCCAC
CA-30 and 50-TGGTGGAGCCTTATAGTGAGTCGTA
TTAAATCGAATTCG-30 for the 11-nt transcript).
For site-directed mutagenesis, a recombinant plasmid
containing a portion (positions 6 to 76) of the sequence
specifying tRNAAla (50-CTTAGCTCAGCTGGGAGAG
CGCCTGCTTTGCACGCAGGAGGTCAGCGGTTCG
ATCCCGCTAGGCTCCACCA-30) was introduced into
pUC18. This plasmid was used as a template for PCR
ampliﬁcation with combinations of two types of mutagenic
primers. The ﬁrst type of primers (50-TTTAATACG
ACTCACTATAGGGGCCTTAGCTCAGCTGGGAG-30)
contained the sequence of the T7 promoter (50-TAAT
ACGACTCACTATA-30), positions 1 to 5 of tRNAAla
(underlined) with all possible single nucleotide substitu-
tions at positions 1 to 4, and 17 nt complementary to
the plasmid template (italics). The second type of primers
(50-TGGTGGAGCCTAGCGGGAT-30) was complemen-
tary to the template (positions 59 to 76 of tRNAAla) with
all possible single nucleotide substitutions in positions 69
to 76 (underlined). Using this approach, transcription of
the wild-type tRNAAla sequence could not occur in the
following step since the pUC derivative used for PCR
ampliﬁcation did not carry the T7 promoter and the ﬁrst
ﬁve bases of the tRNA.
In vitro transcription
The assay was performed at 378C for 4 h in a total volume
of 1ml containing NTPs (4mM each, Amersham), GMP
(20mM), a DNA template (ca. 100 pmol), T7 RNA
polymerase (100mg), Triton 100 (0.05% V/V), MgCl2
(15mM), spermidine (2mM), dithiothreitol (10mM) and
Tris–HCl (40mM, pH 7.5). The reaction mixture was
incubated 20min at 658C, DNAse was added (30U; RQ1
RNase-Free DNAse, Promega) and incubation was
continued for 1 h at 378C. RNA was extracted with one
volume of phenol (pH 4.5), followed by one volume of
phenol/chloroform (1/1V/V), and precipitated with 2
volumes of ethanol at 208C overnight. RNA was
centrifuged at 48C, the pellet was washed three times
with 70% ethanol, dried under vacuum and dissolved in
100 ml of water. The RNA was incubated for 1min at 858C
and slowly (ca. 45min) cooled to room temperature by
switching oﬀ the heating of the water bath. The RNA was
puriﬁed by size exclusion chromatography (Superdex 75
HR 10/30, Pharmacia) in Tris–HCl (25mM, pH 7.5)
containing 100mM NaCl and 5mM MgCl2. The concen-
tration of tRNA was determined by aminoacylation as
described subsequently. A simpliﬁed procedure was used
for the analysis of RNA molecules obtained by site-
directed mutagenesis of tRNAAla. Brieﬂy, size exclusion
chromatography was omitted and the concentration of
tRNA was estimated following ethidium bromide staining
of denaturing polyacrylamide gels containing appropriate
dilution of puriﬁed tRNAAla used as a standard.
Purification of natural tRNAs
The method of Meinnel and Blanquet (22) was used to
extract tRNA from four bacterial species representative of
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the polymorphism at the third position of peptidoglycan
precursors including W. viridescens CIP 102810T (for-
merly Lactobacillus viridescens ATCC 12706), E. faecalis
JH2-2 (23), Enterococcus faecium D344S (17) and
S. aureus COL. Brieﬂy, bacteria were grown at 378C to
mid log phase (optical density of 0.7 at 600 nm) in MRS
broth for W. viridescens or in brain heart infusion broth
(Difco) for the other strains. Bacteria were concentrated
100-fold by centrifugation, resuspended in Tris–HCl
10mM (pH 7.5) containing magnesium acetate 10mM,
and the tRNAs were extracted from bacterial suspensions
with one volume of phenol (pH 4.5). NaCl was added to
obtain a concentration of 0.5M and the tRNAs were
precipitated with 0.7 volume of isopropanol at 808C for
30min. Deacylation was performed in Tris–HCl (pH 8.0)
for 2 h at 378C. The tRNAs were dialysed against water,
lyophilized and dissolved in water. The concentration of
the tRNAs was determined by the absorbance at 260 nm.
Acylation of tRNAs
The concentration of tRNA was determined based on full
aminoacylation with a high concentration of aminoacyl-
tRNA synthetases (800 nM) that was shown to be
suﬃcient for full acylation in less than 1min. The assay
(30ml) contained 50mM Tris–HCl (pH 7.5), 12.5mM
MgCl2, 2mM b-mercaptoethanol, aminoacyl-tRNA syn-
thetases (800 nM) and radiolabeled amino acids 50 mM
(L-[14C]Ala, 6.3GBqmmol1; L-[14C]Ser, 5.8GBqmmol1;
[14C]Gly, 3.7GBqmmol1; Perkin Elmer). The reaction
was incubated 8min at 378C and aminoacyl-tRNAs were
precipitated with 5% TCA and 0.5% casamino acids,
ﬁltered on glass-ﬁber ﬁlters and determined by liquid
scintillation counting.
FemXWv coupled assay
The transferase activity of FemXWv was determined in a
coupled assay containing an auxiliary system to generate
aminoacyl-tRNAs as described by Maillard et al. (13)
with minor modiﬁcations. The assay contained 50mM
Tris–HCl (pH 7.5), 12.5mM MgCl2, 2mM b-mercap-
toethanol, 7.5mM ATP, 800 nM aminoacyl-tRNA
synthetase, 50 mM UDP-MurNAc-pentapeptide, 50 mM
of [14C] amino acids and tRNAs at the concentrations
speciﬁed in the text. The reaction was performed at 308C
with a preincubation of 10min prior to the addition of
FemXWv for synthesis of the aminoacyl-tRNAs by
the auxiliary system. The concentration of FemXWv
(0.5–500 nM) was adjusted to obtain initial velocities in
conditions where transferase activity was rate-limiting.
Under such conditions, the tRNAs were completely
acylated at the onset of the FemXWv reaction and
remained fully acylated during the entire reaction, as
judged by direct determination of aminoacyl-tRNAs.
The reaction was stopped at 958C for 10min and analysed
by descending paper chromatography (Whatman 4MM,
Elancourt, France) with isobutyric acid : ammonia
1M (5 : 3 per vol). Radioactive spots were identiﬁed
by autoradiography, cut-out and counted by liquid
scintillation.
Synthesis ofN-(4-pentenoyl)-L-alanine cyanomethyl ester
To a solution of pentenoic acid (500 ml, 4.9mmol) in DME
(18ml) cooled down to 108C were added successively
N-methylmorpholine (539ml, 4.9mmol) and isobutyl
chloroformate (640ml, 4.9mmol). In another ﬂask, a
mixture of alanine methyl ester hydrochloride (684mg,
4.9mmol) and N-methylmorpholine (539 ml, 4.9mmol) in
DME (2ml) was stirred for 10min at room temperature
before being added dropwise to the ﬁrst solution. The
reaction was stirred overnight at room temperature,
quenched with H2O and DME was evaporated under
reduced pressure. The aqueous layer was extracted twice
with DCM and organic layers were gathered and washed
successively with saturated aqueous NaHCO3 solution,
HCl (0.5M) and brine. After drying over MgSO4 and
concentrated under reduced pressure, the N-(4-pentenoyl)-
L-alanine methyl ester was obtained as a yellowish oil
(92% yield) which was used without any further puriﬁca-
tion. To a solution of this compound (834mg, 4.5mmol)
in THF (20ml) was added a solution of LiOH (0.5M, 2
equiv.) and the mixture was stirred for 30min at room
temperature. The reaction mixture was washed twice with
Et2O. The aqueous layer was acidiﬁed to pH 1 with HCl
and extracted twice with Et2O. The last two organic layers
were dried over MgSO4 and concentrated under reduced
pressure to give the N-(4-pentenoyl)-L-alanine as a yellow-
ish oil (48% yield) which was used without further
puriﬁcation. To a solution of this compound (325mg,
1.9mmol) in CH3CN (5ml) were added trietylamine
(1.14ml, 8.17mmol) and chloroacetonitrile (300 ml,
4.75mmol); the mixture was stirred overnight at room
temperature and concentrated to dryness under reduced
pressure. The residue was dissolved in AcOEt and H2O,
the organic layer was dried over MgSO4 and concentrated.
A puriﬁcation by ﬂash chromatography (cyclohexane/
EtOAc : 2/1 to 1/1) aﬀorded the N-(4-pentenoyl)-L-alanine
cyanomethyl ester as a yellow oil in 72% yield. ½25D 42
(c 1, CHCl3);
1H NMR (250MHz, CDCl3) : d1.40 (d, 3H, J
7.4), 2.3 (bs, 4H), 4.5 (dq, 1H, J 8.0), 4.74 (d, J 15), 4.9–5.1
(m, 2H), 5.77 (m, 1H), 6.36 (bd, 1H, J 6.8); 13C NMR
(63MHz, CDCl3): d 17.6, 29.3, 35.2, 47.7, 49.0, 114.1,
115.7, 136.8, 171.7, 172.4.
Semi-synthesis of Ala-tRNAAla analogues
Chemical aminoacylation of the hybrid dinucleotide
50-phospho-20-deoxyribocytidylylriboadenosine (pdCpA)
by N-(4-pentenoyl)-L-alanine cyanomethyl ester was per-
formed as previously described (24,25). Ligation of
pdCpA-Ala-pentenoyl (400mM) to the 74-nt in vitro
transcript (4 mM) lacking the last 30 nucleotide C75–A76
of tRNAAla was performed with the puriﬁed T4 RNA
ligase (above) in 50 ml of 50mM HEPES buﬀer (pH 7.5)
containing 0.75mM ATP, 15mM MgCl2, and 10%
DMSO (per volume) for 2 h at 378C. The Ala-tRNA
substrate (ca. 200 pmol) was deprotected with 5mM I2 in
THF/H2O (1/1) (25), puriﬁed by ethanol precipitation,
and immediately incubated with FemXWv (5 pmol) and
UDP-MurNAc-pentapeptide (200 pmol) in 10 ml of 50mM
Tris–HCl (pH 7.5) containing 12.5mM MgCl2 and 2mM
b-mercaptoethanol. The reaction was incubated for 2 h
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at 308C, desalted using a micro column (ZipTipC18,
Millipore), and analyzed by nanoelectrospray mass
spectrometry in the positive mode in order to detect
formation of UDP-MurNAc-hexapeptide.
Docking model of the FemXWv-tRNA
Ala complex
The model of tRNAAla was built from tRNAAsp in
complex with E. coli aspartyl tRNA-synthetase (26) by
replacing nucleotides of E. coli tRNAAsp by the E. faecalis
tRNAAla counterparts. The tRNAAla was manually
docked in the FemXWv active site (PDB code 1P4N) (11)
using the position of puromycin in the active site of the
leucyl/phenylalanyl-tRNA-protein transferase to position
the 30-end A76 of the tRNAAla (PDB code 2DPT) (27).
The structure was energy minimized in 100 steps with a
dielectric constant of 1, using the CNS program (28).
The puromycin: leucyl/phenylalanyl-tRNA synthetase
complex was used to position the 30-end of the acceptor
arm of tRNAAla since this transferase and FemXWv share
a common fold indicating that their tRNA-binding sites
are likely to be structurally related (11,27).
RESULTS
In vivo specificity of the FemXWv transferase
Cytoplasmic peptidoglycan precursors were extracted
from W. viridescens to identify the amino acid incorpo-
rated by FemXWv in vivo (Figure 1). The main precursor
had a monoisotopic mass of 1221.40. Sequencing by
tandem mass spectrometry indicated that this precursor
consisted of UDP-MurNAc, a linear pentadepsipeptide
terminating in D-lactate (L-Ala1-D-iGlu2-L-Lys3-D-Ala4-
D-Lac5) and an L-Ala residue linked to the side chain of
L-Lys3. Production of D-Lac-ending precursors is in
agreement with phenotypic expression of glycopeptide
resistance by W. viridescens (data not shown) since
these precursors bind the drugs with reduced aﬃnity
(29). Minor amounts of UDP-MurNAc-L-Ala1-D-iGlu2-
L-Lys3-D-Ala4 (UDP-MurNAc-tetrapeptide) with a
monoisotopic mass of 1078.31 and of UDP-MurNAc-
tetrapeptide with a side chain consisting of a single L-Ala
(1149.35) were also detected (Figure 1). Incorporation
of amino acid other than L-Ala into the side chain was
not detected indicating that FemXWv is highly speciﬁc for
L-Ala in vivo.
Synthesis of the side chain of peptidoglycan precursors
was also assessed by analyzing the structure of mature
peptidoglycan by mass spectrometry. Identiﬁcation of 120
peptidoglycan fragments obtained by digestion of the cell
wall by muramidases revealed variations in the length of
stem peptides and of side chains in combination with
various degree of oligomerization (Figure 1 and data
not shown). Brieﬂy, the stem of monomers consisted of
a tripeptide (L-Ala1-D-iGln2-L-Lys3) or a tetrapeptide
(L-Ala1-D-iGln2-L-Lys3-D-Ala4) in similar amounts indicat-
ing that the L-Lys3-D-Ala4 and D-Ala4-D-Lac5 peptide
bonds were cleaved by L,D and D,D-carboxypeptidases,
respectively (18). The side chains of monomers mainly
consisted of the sequence L-Ala-L-Ser and L-Ala-L-Ser-
L-Ala. Side chains consisting of a single L-Ala were less
abundant and unsubstituted monomers were not detected.
These observations indicate that FemXWv eﬃciently and
speciﬁcally adds L-Ala to the precursors in agreement with
the analysis of the cytoplasmic pool of UDP-MurNAc-
peptides. The second (L-Ser) and third (L-Ala) residues of
the side chain were added by unknown Fem transferases,
since FemXWv adds a single residue in the in vitro coupled
assay containing the accessory systems for Ala-tRNAAla
and Ser-tRNASer synthesis (Figure 2 and data not shown).
The second and third residues were added after the
transfer of the phospho-MurNAc-peptide moiety of the
precursor to the lipid carrier since a single L-Ala residue
was detected in the nucleotide precursors (Figure 1).
The peptidoglycan of W. viridescens contained multimeric
structure ranging from dimers to hexamers. The
cross-bridges contained the sequence L-Ala-L-Ser and
L-Ala-L-Ser-L-Ala indicating that the D,D-transpeptidases
used acceptor containing at least two residues in their side
chains.
In conclusion, analyses of the structure of peptidogly-
can and its precursors indicated that FemXWv only adds
L-Ala at the ﬁrst position of L-Ala-L-Ser and L-Ala-L-
Ser-L-Ala side chains. Incorporation of L-Ala substitutes
in more than 1% of the precursors would have been easily
detected since peptidoglycan fragments containing Gly,
D-Asp and L-Ser are readily detected by electrospray mass
spectrometry (16,17).
Specificity of the FemXWv transferase for tRNAs obtained
by in vitro transcription
In order to compare the catalytic eﬃciency of FemXWv
with diﬀerent aminoacyl-tRNAs, kinetics of synthesis of
UDP-MurNAc-hexapeptides containing Ala (Figure 3A),
Ser (Figure 3B), and Gly (Figure 3C) were performed
at diﬀerent aminoacyl-tRNA concentrations. The turn-
over number of FemXWv was deduced from the indi-
vidual kinetics and plotted against the aminoacyl-tRNA
UDP-MurNAc-pentapeptide
UDP-MurNAc-hexapeptide
AA-tRNA
tRNA
FemX
ATP + AA
AMP + PPi
AA-RS
Figure 2. Coupled assay for UDP-MurNAc-hexapeptide synthesis. The
auxiliary system used to generate aminoacyl-tRNA (AA-tRNA)
involves acylation of tRNA with a radiolabeled amino acid by
aminoacyl-tRNA synthetases (AA-RS). Puriﬁed alanyl-tRNA synthe-
tase (AlaRS), seryl-tRNA synthetase (SerRS) and glycyl-tRNA
synthetase (GlyRS) were used in this study. FemXWv transfers the
amino acids from the aminoacyl-tRNAs to the e -amino group of L-Lys
at the third position of UDP-MurNAc-pentapeptide to form the
corresponding hexapeptide which was determined by liquid
scintillation.
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concentrations (Figure 3D–F). The linear relationship
indicates that the reaction conditions meet the ﬁrst order
conditions with respect to aminoacyl-tRNAs in agreement
with the Km value of 1.7mM previously reported for Ala-
tRNAAla (13). Ser-tRNASer and Gly-tRNAGly were used
17- and 38-fold less eﬃciently than Ala-tRNAAla by
FemXWv (36 and 16 versus 605min
1 mM1, respectively;
Table 1).
In vitro specificity of the FemXWv transferase for natural
tRNAs
The relative eﬃciency of FemXWv with natural tRNAs
from W. viridescens, S. aureus, E. faecalis and E. faecium
was evaluated based on determination of the turnover
number of the enzyme at four aminoacyl-tRNA concen-
trations as performed for in vitro transcripts (data not
shown and Table 1). The highest FemXWv turnover
Figure 3. Catalytic eﬃciency of FemXWv with diﬀerent tRNAs obtained by in vitro transcription. Kinetics of transfer of Ala (A), Ser (B) and Gly (C)
from aminoacyl-tRNAs to UDP-MurNAc-pentapeptide was determined with four concentrations of tRNAs (ﬁlled square, 0 mM; ﬁlled circle,
0.025mM; open circle, 0.05mM; open square, 0.075mM; open circle, 0.1 mM). The concentrations of the two enzymes in the coupled assay were
adjusted to obtain initial velocities in conditions where the transferase activity of FemXWv was rate-limiting and the tRNAs were completely
acylated by the aminoacyl-tRNA synthetases, (A) FemXWv (0.5 nM), alanyl-tRNA synthetase (0.8 mM); (B) FemXWv (2 nM), seryl-tRNA synthetase
(0.8 mM); (C) FemXWv (10 nM), glycyl-tRNA synthetase (0.8 mM). The FemXWv turnover numbers deduced from the kinetics were plotted as a
function of the concentrations of Ala-tRNAAla (D), Ser-tRNASer (E), Gly-tRNAGly (F). The slopes (y) provide an estimate of the relative
catalytic eﬃciencies of FemXWv for the transfer of Ala, Ser and Gly at non-saturating concentrations of aminoacyl-tRNAs (turnover per min and per
mM of tRNAs).
Table 1. Relative turnover numbers of FemXWv with diﬀerent tRNAs
In vitro transcript Natural tRNAs
W. viridescens
(L-Ala-L-Ser -L-Ala)
S. aureus (Gly5) E. faecalis (L-Ala2) E. faecium (D-iAsn)
tRNAAla 605 54 2890 350 410 45 570 57 830 78
tRNASer 36 1 29 3 8 1 32 4 37 2
tRNAGly 16 1 0.75 0.07 0.65 0.06 1.44 0.10 1.99 0.20
The relative catalytic eﬃciency of FemXWv for the transfer of Ala, Ser and Gly at non-saturating concentrations of aminoacyl-tRNAs
(turnover per min and per mM of tRNAs) was determined for tRNA obtained by in vitro transcription and for natural tRNAs. The in vitro
transcripts had the sequence of tRNAs from E. faecalis (tRNAAla and tRNASer) or S. aureus (tRNAGly; see Materials and methods section). The
natural tRNAs were extracted from four bacterial species representative of the diversity of the side chain of peptidoglycan precursors (indicated in
parenthesis).
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number was observed with Ala-tRNAAla extracted from
W. viridescens. The Ser-tRNASer and Gly-tRNAGly were
used 100- and 4000-fold less eﬃciently than Ala-tRNAAla
(29 and 0.75 versus 2890min1 mM1, respectively).
FemXWv was less speciﬁc with heterologous tRNAs
from S. aureus, E. faecalis and E. faecium. This was
mainly due to the fact that heterologous tRNAAla were
not eﬃciently used by FemXWv. The heterologous tRNAs
were extracted from bacterial species representative of the
diversity in the sequence and the mode of assembly of
the side chain of peptidoglycan precursors. E. faecium
produces an ATP-dependent ligase for incorporation of
D-Asp whereas S. aureus and E. faecalis produce Fem
transferases for synthesis of Gly5 and L-Ala2 side chains
(6). FemXWv displayed similar catalytic eﬃciencies with
the heterologous tRNAs irrespective of the mode of
synthesis of the side chain in the three species.
The catalytic eﬃciencies of FemXWv with tRNA
Ala
obtained by in vitro transcription or present in the tRNA
pool extracted from E. faecalis were very similar (605
versus 570min1 mM1). Since the genome of E. faecalis
contains a single tRNAAla sequence present in triplicate,
this result indicates that post-transcriptional modiﬁcation
of the tRNA does not modulate the activity of FemXWv.
Similar catalytic eﬃciencies were also observed for
tRNASer obtained in vitro or present in the tRNA pool
of E. faecalis (36 versus 32min1 mM1). For tRNAGly,
the in vitro transcript was used more eﬃciently than
the natural tRNAs from the four species (16 versus
0.65–1.99min1 mM1). This suggests that unknown
post-transcriptional modiﬁcations of tRNAGly may
impair FemXWv activity.
Identification of a minimal RNA substrate in the
AlaRS-FemXWv coupled assay
Various derivatives of the E. faecalis tRNAAla (Figure 4)
were tested as substrates of AlaRS and FemXWv in the
coupled assay (Figure 2) for UDP-MurNAc-hexapeptide
synthesis. Deletion of the anticodon and pseudouridine
arms of tRNAAla resulted in two minihelices, with or
without bulged U8, which were both functional in the
coupled assay. Formation of UDP-MurNAc-hexapeptide
was also obtained with a 24-nt microhelix consisting of the
acceptor stem of tRNAAla and a loop of 6 nt. Finally, an
RNA duplex consisting only of the acceptor stem was also
functional. These results indicate that the bases essential
for FemXWv and AlaRS activities are all located within
the acceptor stem of tRNAAla. We therefore focused the
following mutagenesis studies on the acceptor stem of
tRNAAla although we have not excluded the possibility
that additional region of the tRNA might modulate
enzyme activity.
Development and validation of a novel method for
saturation mutagenesis of the acceptor stem of tRNAAla
To facilitate site-directed mutagenesis of the DNA
template for in vitro transcription of tRNAAla by T7
RNA polymerase, we have developed a method based on
PCR ampliﬁcation using mutagenic primers. In the
classical method (21), the 50-end of the DNA template
that determines the 30-end of the run oﬀ transcript is
generated by digestion of a plasmid by the restriction
endonuclease BstNI. In this study, the 50-end of a primer
used for PCR ampliﬁcation of the DNA template
provided an alternate way to deﬁne the 30-end of the
tRNA transcript. Twenty-four mutagenic primers were
used to introduce all possible single nucleotide substitu-
tions in positions C69 to A76 of the acceptor stem. The
50-end of the in vitro transcript was deﬁned by the
localization of the T7 promoter, which was incorporated
at the 50-end of the second primer used for PCR
ampliﬁcation. The mutagenic primers also contained the
sequence corresponding to bases 1 to 22 of tRNAAla,
thereby allowing the introduction of all possible single
nucleotide substitutions in positions 1 to 4. The plasmid
template used for PCR ampliﬁcation did not contain the
T7 promoter sequence. Thus, the wild-type tRNAAla
sequence could not originate from transcription of the
plasmid template. In preliminary experiments, we com-
pared tRNAAla with the wild-type sequence obtained by
in vitro transcription of DNA matrices generated by PCR
or by the classical digestion of a plasmid template with
BstNI. The two types of tRNAAla preparations were
equivalent in conditions where the tRNA substrate and
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Figure 4. Functional RNA molecules in the synthesis of UDP-
MurNAc-hexapeptide by AlaRS and FemXWv in the coupled assay.
The 76-nt RNA corresponds to the only tRNAAla of E. faecalis. The
minimal RNA substrate in the AlaRS-FemXWv coupled assay was a
duplex (7+11 nt) mimicking the acceptor stem of the tRNAAla.
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FemXWv were rate limiting (data not shown). We also
checked that the ﬁdelity of the DNA polymerase used for
the PCR was suﬃcient to avoid false positives. This
was established by showing that several substitutions
abolished formation of the UDP-MurNAc-hexapeptide
product of FemXWv in the coupled assay (Figure 5, see
subsequently).
Impact of single nucleotide substitutions in tRNAAla
Nucleotide substitutions were introduced at positions 1 to
4 of tRNAAla and residual activity was determined by the
coupled AlaRS-FemXWv assay (Figure 5). All substitu-
tions at position 3 abolished formation of the UDP-
MurNAc-hexapeptide indicating that G3 is essential. At
position 2, low residual activity was detected only for the
G2A and G2C substitutions. All substitutions were
tolerated at positions 1 and 4 with various impacts on
residual activities. Analysis of the complementary strand
by the same method identiﬁed three essential bases
(C72, C71 and U70). Relatively high residual activities
were detected for position C69. Several substitutions were
tolerated in the single-strand ACCA extremity of the
acceptor stem and none of the four bases was essential.
In conclusion, analysis of single substitutions identiﬁed
four bases, C72, C71 and G3–U70 that were essential for
synthesis of UDP-MurNAc-hexapeptide by AlaRS and
FemXWv.
Impact of double nucleotide substitutions in tRNAAla
All 15 possible combinations of nucleotides were intro-
duced in base pairs G1–C72, G2–C71, G3–U70 and G4–C69
using pairs of mutagenic primers and residual activity
was determined in the coupled AlaRS-FemXWv (Figure 6).
For the G1–C72 base pair, C at position 72, rather than a
Watson–Crick base pair, was essential for enzyme activity
since tRNAs containing C1–G72, A1–U72, U1–A72 did not
support UDP-MurNAc-hexapeptide synthesis. In the
following base pair, residual activity was only detected
for two of the 15 combinations, A2–C71 and C2–C71,
revealing again that destabilization of the acceptor stem is
not the main factor that determines loss of activity. At
position G3–U70, none of the 15 combinations were
tolerated. Finally, synthesis of UDP-MurNAc-hexapeptide
was obtained with the set of 16 tRNAs containing all
base combinations at positions 4 and 69. These results
conﬁrmed that four speciﬁc bases, C72, C71 and the G3–U70
pair, are essential for UDP-MurNAc-hexapeptide synth-
esis. None of the double substitutions that restored
Watson–Crick base pairs compensated for substitution at
C72 and C71. Thus, modiﬁcation of the sequence rather
than destabilization of the acceptor stem was the primary
impact of nucleotide substitutions at these two positions.
Figure 6. Histogram showing residual (%) UDP-MurNAc-hexapeptide
synthesis in the AlaRS-FemXWv coupled assay with derivatives
of tRNAAla (76-nt) harboring all possible combinations in base pairs
G1–C72 (A), G2–C71 (B), G3–U70 (C) and G4–C69 (D). The standard
assay was performed with AlaRS (800 nM), FemXWv (500 nM),
L-[14C]Ala (50 mM) and the diﬀerent tRNAs (ca. 5 mM). The reaction
was incubated for 2 h at 308C. Under these conditions, total L-[14C]Ala
(0.5 nmol) was incorporated into UDP-MurNAc-hexapeptide when
RNA with the wild type sequence was used (100%, indicated by a star).
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Figure 5. Residual (%) UDP-MurNAc-hexapeptide synthesis in the
AlaRS-FemXWv coupled assay with derivatives of tRNA
Ala (76-nt)
harboring single base substitutions in the acceptor stem. The standard
assay was performed with AlaRS (800 nM), FemXWv (500 nM),
L-[14C]Ala (50 mM) and the diﬀerent tRNAs (ca. 5.0 mM). The reaction
was incubated for 2 h at 308C. Under these conditions, total L-[14C]Ala
(0.5 nmol) was incorporated into UDP-MurNAc-hexapeptide when
RNA with the wild-type sequence was used (100%). ND, not detected.
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Semi-synthesis of analogues of Ala-tRNAAla
Detection of UDP-MurNAc-hexapeptide synthesis in the
coupled assay used above implies that nucleotide sub-
stitutions are tolerated both by the AlaRS and by
FemXWv. Thus, the assay provides a rapid method to
determine whether nucleotide substitutions are tolerated
by FemXWv provided that the modiﬁed tRNA
Ala mole-
cules are substrate of the AlaRS. The assay is highly
sensitive to qualitatively detect residual activity since each
tRNA molecule can participate to several catalytic cycles
(Figure 2). However, the absence of UDP-MurNAc-
hexapeptide synthesis in the coupled assay, as observed
for the substitutions at positions C72, C71 and G3–U70,
may indicate that the modiﬁed tRNAs are not substrate of
AlaRS although they can be used by FemXWv. Semi-
synthesis of Ala-tRNAAla analogues harboring these
substitutions was therefore developed to obtain esteriﬁed
tRNAAla independently from the AlaRS (Figure 7A). This
approach was originally developed to introduce non-
natural amino acids into proteins by using in vitro coupled
transcription-translation systems (30). Brieﬂy, a dinucleo-
tide esteriﬁed by an amino acid analogue is obtained by
organic synthesis (Figure 7B) and added to an incomplete
tRNA lacking the 30-end CA dinucleotide using the T4
RNA ligase (30). The ligation restores the complete tRNA
sequence with a 30 esteriﬁed residue. A 20 deoxycytidine is
incorporated into the dinucleotide to facilitate its synth-
esis. In preliminary experiments, we generated a FemXWv
substrate by this approach which contained the wild-type
tRNAAla sequence and L-Ala as the 30 amino acyl group
(Figure 7C). Transfer of L-Ala from this Ala-tRNAAla
analogue to UDP-MurNAc-pentapeptide was detected by
mass spectrometry indicating that FemXWv tolerates
substitution of a ribose by a 20deoxyribose at position 75.
Semi-synthetic Ala-tRNAAla analogues containing
Watson–Crick G3–C70 or A3–U70 base pairs instead of
G3–U70 were substrates of FemXWv. Thus, neither G at
position 3 nor U at position 70 was necessary for
transferase activity. In addition, FemXWv did not require
a wobble base pair at positions 3–70. None of the 15 base
combinations were tolerated at these positions in the
AlaRS-FemXWv coupled assay (Figure 6, above). These
negative results can be attributed to the lack of amino
acylation by the AlaRS since the semi-synthetic
Ala-tRNAAla analogues containing G3–C70 and A3–U70
were substrate of FemXWv. In contrast, C
72 and C71,
identiﬁed as essential in the coupled assay (Figure 5,
above), were also found to be essential for FemXWv
activity since introduction of the C72G and C71G
substitutions by semi-synthesis abolished formation of
UDP-MurNAc-hexapeptide. In conclusion, C72 and C71,
but not G3–U70, were essential for FemXWv indicating
that the mode recognition of the tRNA body by this
enzyme and AlaRS are diﬀerent.
DISCUSSION
Synthesis of the side chain of peptidoglycan precursors by
Fem transferases in Gram-positive bacteria implies that
translation and peptidoglycan synthesis share common
aminoacyl-tRNA synthetases and tRNAs. Fem trans-
ferases have evolved to redirect a portion of the
aminoacyl-tRNAs toward peptidoglycan synthesis. The
speciﬁcity of these enzymes is essential since the side chain
is used by the transpeptidases in the last cross-linking step
of peptidoglycan synthesis (Introduction section and
Figure 1A). In this study, we have investigated tRNA
recognition by a model transferase, FemXWv from
W. viridescens, to identify and compare the identity
determinants used by aminoacyl-tRNA synthetases and
Fem transferases.
In vivo evaluation of the speciﬁcity of FemXWv based on
extensive analyses of the structure of mature peptidogly-
can and its precursors (Figure 1) revealed that this enzyme
exclusively uses Ala-tRNAAla for aminoacyl transfer.
Evaluation of homologous tRNAs extracted from
W. viridescens indicated that FemXWv is also highly
speciﬁc in vitro since Ser-tRNASer and Gly-tRNAGly were
used 100- and 4000-fold less eﬃciently than Ala-tRNAAla,
respectively (Table 1). Comparison of in vitro transcripts
and natural tRNAs revealed similar catalytic eﬃciencies
indicating that post-transcriptional modiﬁcations do not
contribute to discrimination between Ala-tRNAAla and
Ser-tRNASer (Table 1). In contrast, unknown post-
transcriptional modiﬁcations might act as negative
(anti-determinant) elements for Gly-tRNAGly since incor-
poration of Gly was 25-fold less eﬃcient with natural
tRNAs than with in vitro transcripts (Table 1). FemXWv
retained preferential incorporation of alanine with hetero-
logous tRNAs extracted from related Gram-positive
species, although the capacity of the enzyme to discrimi-
nate between the diﬀerent tRNAs was reduced mainly
because heterologous Ala-tRNAAla were used less eﬃ-
ciently than Ala-tRNAAla from W. viridescens. The use of
heterologous Ala-tRNAAla and Ser-tRNASer from E. coli
in a previous study may therefore account for the reported
poor discrimination of the two aminoacyl-tRNAs by
FemXWv (14).
To identify the tRNA elements essential for FemXWv
activity, deletions were introduced into tRNAAla revealing
that the acceptor stem is suﬃcient for the alanine
transferase activity of FemXWv (Figure 4). Site-directed
mutagenesis identiﬁed four bases (C72, C71 and G3–U70)
essential for UDP-MurNAc-hexapeptide synthesis in the
coupled AlaRS-FemXWv assay (Figure 5). Introduction of
double nucleotide substitutions showed that C72 and C71
were both essential since destabilization of the acceptor
stem was not the primary impact of nucleotide substitu-
tions at these two positions (Figure 6). Site-directed
mutagenesis (Figures 5 and 6) combined to semi-synthesis
(Figure 7) showed that the identity determinants of the
E. faecalis AlaRS and FemXWv are overlapping but
distinct (Figure 8A). In particular, the G3–U70 base pair of
tRNAAla, which is the main identity determinant of
AlaRS from bacteria, archaea and eukarya (31,32),
occasionally found at positions 2–71 (33,34), was non-
essential to the alanyl transferase activity of FemXWv
since nucleotide substitutions at positions 3 and 70 were
both tolerated by the enzyme (Figure 8A). Modeling of
tRNAAla in the FemXWv active site (Figure 8B) indicated
that the ﬁrst two base pairs (G1–C72 and G2–C71) of the
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acceptor stem and the ACCA end are likely to be in close
contact with the protein. The lack of direct interaction
between the 3–70 base pair and FemXWv is in agreement
with the non-essential nature of G3 and U70 for the alanyl
transferase activity of this enzyme. Substitutions that
restored Watson–Crick base pairing at position 3–70 did
not abolish FemXWv activity. Thus, indirect recognition of
the wobble base pair through a structural perturbation in
the acceptor stem (34,35) appears also to be excluded for
FemXWv.
The capacity of FemXWv to discriminate between
diﬀerent aminoacyl-tRNA is likely to depend both upon
the tRNA body and the esteriﬁed amino acid as
demonstrated for elongation factor EF-Tu that delivers
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Figure 7. Semi-synthesis of Ala-tRNAAla analogues. (A) The protected dinucleotide pdCpA-Ala-pentenoyl was ligated to a 74-nt in vitro transcript
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aminoacyl-tRNAs to the ribosome during translation (36).
For this protein, the aﬃnities for the tRNA and the amino
acid have compensatory role to ensure roughly equiva-
lent aﬃnities for all elongator aminoacyl-tRNAs. The
sequence-dependent recognition of the tRNA body
involves hydrogen bonding between a Glu residue of the
protein and the amino group of a guanine located in the
minor groove of the T-stem (base pair 51–63). Aminoacyl-
tRNA recognition by the eubacterial leucyl/phenylalanyl-
tRNA-protein transferase (L/F-transferase) involves a
diﬀerent mechanism (27). This enzyme conjugates leucine
or phenylalanine to the N-terminus of proteins triggered
to proteolytic degradation using Leu-tRNALeu or Phe-
tRNAPhe as a substrate. The C-terminal domain of
L/F-transferase belongs to the GCN5-related N-transfer-
ase fold as the two domains of FemXWv (11). The enzyme
contains a hydrophobic pocket that accommodates Leu
and Phe (and Met and Trp less eﬃciently) ensuring amino
acid speciﬁcity (27). Recognition of the tRNA body occurs
in a sequence-independent manner. Based on modeling,
recognition involves the phosphate backbone of the
bottom region of the D-stem and of the 30 region of the
acceptor stem. The recognition of amino acyl-tRNAs by
L/F-transferase and EF-Tu is competitive. It has been
proposed that L/F-transferase might overcome this
competition by using a diﬀerent site in the aminoacyl-
tRNAs, presumably in the D-loop, that does not overlap
with the EF-Tu binding site. A similar mechanism may
operate for FemXWv which is expected to compete with
EF-Tu for uptake of aminoacyl-tRNAs.
In conclusion, modeling and mutagenesis of tRNAAla
has provided key information for rational design of
FemXWv inhibitors since the bases essential for FemXWv
activity were mapped in a relatively small portion of the
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Figure 8. Recognition of tRNAs by alanyl-tRNA synthetases and FemXWv. (A) Sequence of the tRNA
Ala acceptor stem. The bases essential for
formation of UDP-MurNAc-hexapeptide in the coupled AlaRS-FemXWv assay are boxed. Among these four bases, only C
72 and C71 are essential for
FemXWv activity as shown by comparing the impact of substitutions in the coupled assay and the direct determination of FemXWv activity using
semi-synthetic substrates (right panel). (B) Model of FemXWv-tRNA
Ala interaction showing domains I (blue) and II (pink) of FemXWv and the
tRNAAla (red) and UDP-MurNAc-pentapeptide (green) substrates.
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tRNAAla acceptor stem comprising a total of eight bases
including its single-stranded ACCA end and the distal
base pairs G1–C72 and G2–C71. Design of substrate
analogues should therefore target this region of the
aminoacyl-tRNA substrate. In addition, the diﬀerent
modes of recognition of the acceptor stem by FemXWv
and the AlaRS suggests that it will be feasible to achieve
inhibitor selectivity for the peptidoglycan biosynthetic
enzyme.
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